C10390920T
C1085T
Q287term | da-PA; Q287term | da-PB; Q287term | da-PC; Q287term | da-PD
Q287term
Amino acid replacement: Q287term.
Nucleotide substitution: C1085T.
normal Southern
Homozygotes have no cpo expressed in PNS at any stage of development, though cpo continues to be expressed in the CNS and a cluster of cells round the posterior spiracle.
Interacts with RpII140wimp maternal effect.
apparent amorph; recessive lethal; lethal with da1, Df, or other lethal alleles
Sxlf1, da[+]/da2 has partially lethal - majority die | dominant phenotype, enhanceable by Df(3R)pps1/+
Sxlf1, da[+]/da2 has partially lethal - majority die | dominant phenotype, enhanceable by pps+tJa/Df(3R)pps1/+
da[+]/da2 is an enhancer | maternal effect of partially lethal | female | maternal effect phenotype of Sxl[+]/SxlfP7B0, snfJ210
Sxl[+]/SxlfP7B0, da2 has partially lethal | female | parental effect phenotype
Sxlf1, da[+]/da2 has partially lethal - majority die | dominant phenotype
da[+]/da2 is an enhancer of follicle cell phenotype of Egfrf3/Egfrt1
da[+]/da2 is an enhancer of follicle cell phenotype of brnfs.107/brnl.6P6
da[+]/da2 is an enhancer of follicle cell phenotype of brnfs.107
Stat92E06346, da2 has follicle cell phenotype
da2, dx1 has follicle cell phenotype
da2, dxS1M has follicle cell phenotype
Dsor1[+]/Dsor1S-1221, da2 has follicle cell phenotype
Ras85De1B/Ras85D[+], da2 has follicle cell phenotype
Sose4G/Sos[+], da2 has follicle cell phenotype
Stat92E[+]/Stat92E06346, da2 has follicle cell phenotype
Su(dx)[+]/Su(dx)2, da2 has follicle cell phenotype
da2, drk[+], drke0A, drke0A has follicle cell phenotype
da2, grk6/grk6 has follicle cell phenotype
da2, dx1/dx[+] has follicle cell phenotype
da2, dxS1M/dx[+] has follicle cell phenotype
da2, grk3, grk3, grk[+] has follicle cell phenotype
da2, grk6, grk6, grk[+] has follicle cell phenotype
da2, hop2/hop[+] has follicle cell phenotype
da2, Raf7/phl[+] has follicle cell phenotype
da2, pnt[+]/pnt07825 has follicle cell phenotype
da2, rl[+]/rlS-135 has follicle cell phenotype
da2, rl[+]/rlSem has follicle cell phenotype
da2, spi1/spi[+] has follicle cell phenotype
Su(dx)2, da2 has follicle cell phenotype
da2, spi3/spi[+] has follicle cell phenotype
Su(H)[+]/Su(H)1, da2 has follicle cell phenotype
da2, rlSem has follicle cell phenotype
da2, spi1 has follicle cell phenotype
da2, hop2 has follicle cell phenotype
da2, pnt07825 has follicle cell phenotype
da2, drke0A/drke0A has follicle cell phenotype
da2, spi3 has follicle cell phenotype
da2, rlS-135 has follicle cell phenotype
da2, Raf7 has follicle cell phenotype
Dsor1S-1221, da2 has follicle cell phenotype
Ras85De1B, da2 has follicle cell phenotype
Su(H)1, da2 has follicle cell phenotype
Sose4G, da2 has follicle cell phenotype
da2, grk3/grk3 has follicle cell phenotype
Transheterozygotes with toc alleles exhibit ovary defects.
Double heterozygotes of Nl1N-ts1 or Dl9 with da2 show ovarian defects as for mutant da genotypes: stalkless ovaries, compound egg chambers and no distinction between germarium and vitellarium. Double heterozygotes of mamIL113 with da2 show ovarian defects as for mutant da genotypes and doubly heterozygous N and Dl mutants.